SEMINARS IN THROMBOSIS AND HEMOSTASIS

Scope & Guideline

Exploring breakthroughs in cardiovascular and hematologic health.

Introduction

Delve into the academic richness of SEMINARS IN THROMBOSIS AND HEMOSTASIS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0094-6176
PublisherTHIEME MEDICAL PUBL INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1974 to 2024
AbbreviationSEMIN THROMB HEMOST / Semin. Thromb. Hemost.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address333 SEVENTH AVE, NEW YORK, NY 10001

Aims and Scopes

SEMINARS IN THROMBOSIS AND HEMOSTASIS is dedicated to advancing the understanding and management of thrombosis and hemostasis through comprehensive research and critical reviews. The journal aims to provide a platform for the dissemination of innovative research findings and clinical insights, with a strong emphasis on interdisciplinary collaboration.
  1. Thrombosis and Hemostasis Mechanisms:
    The journal focuses on the underlying biological mechanisms of thrombosis and hemostasis, exploring the molecular and cellular pathways involved in coagulation, platelet function, and fibrinolysis.
  2. Clinical Management and Guidelines:
    It emphasizes practical clinical applications, including guidelines for diagnosis, treatment, and management of various coagulation disorders and thrombotic events.
  3. Emerging Therapies and Technologies:
    The journal highlights advancements in therapeutic approaches and diagnostic technologies, including gene therapy, novel anticoagulants, and point-of-care testing.
  4. Epidemiological Studies and Risk Assessment:
    Research in the journal addresses epidemiological aspects of thrombotic conditions, identifying risk factors, and assessing the impact of interventions on patient outcomes.
  5. Translational Research:
    SEMINARS IN THROMBOSIS AND HEMOSTASIS bridges the gap between laboratory findings and clinical practice, promoting research that translates into real-world applications for patients.
The journal has identified several trending and emerging themes, reflecting the dynamic nature of research in thrombosis and hemostasis. These themes demonstrate a response to contemporary challenges and advances in the field.
  1. COVID-19 Related Thrombosis:
    Research examining the thromboembolic complications associated with COVID-19 has surged, highlighting the need to understand the virus's impact on coagulation and management strategies.
  2. Gene Therapy and Innovative Treatments:
    There is a growing interest in gene therapy and other novel treatment modalities for inherited bleeding disorders and thrombosis, reflecting advancements in biotechnology and personalized medicine.
  3. Multidisciplinary Approaches to Thrombosis:
    Emerging studies emphasize interdisciplinary strategies that integrate insights from immunology, oncology, and genetics to address complex thrombotic conditions.
  4. Patient-Centered Outcomes and Quality of Life:
    Research focusing on patient-reported outcomes, quality of life, and the psychosocial aspects of living with thrombotic disorders is gaining traction, indicating a shift towards holistic patient care.
  5. Machine Learning and Predictive Analytics:
    The application of machine learning and predictive analytics for risk assessment and management of thrombosis is increasingly prominent, showcasing the integration of technology in clinical practice.

Declining or Waning

While SEMINARS IN THROMBOSIS AND HEMOSTASIS continues to evolve, certain themes have shown a decline in prominence in recent years. These waning areas reflect shifting research priorities and emerging challenges in the field.
  1. Traditional Anticoagulation Methods:
    There is a noticeable reduction in studies focusing solely on traditional anticoagulation methods, as the field shifts towards exploring more advanced therapies and personalized approaches.
  2. Basic Research in Hemostasis:
    Research that does not translate into clinical application or lacks direct relevance to patient care has seen a decline, as the journal emphasizes translational and applied research.
  3. Historical Perspectives without Current Relevance:
    Papers focused on historical accounts or perspectives without a clear connection to current clinical practices or advancements have become less frequent, reflecting a shift towards contemporary issues.

Similar Journals

SEMINARS IN ULTRASOUND CT AND MRI

Exploring the Depths of Radiological Science
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-2171Frequency: 6 issues/year

SEMINARS IN ULTRASOUND CT AND MRI is a prestigious academic journal dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Published by W B SAUNDERS CO-ELSEVIER INC, this journal has been a cornerstone of scholarly communication since 1984, providing a platform for high-quality research and review articles that enhance the understanding of diagnostic imaging techniques. With a current impact factor reflected in its Q3 quartile ranking among 333 journals in its category, it remains a valuable resource for researchers and clinicians alike. The journal's focus includes but is not limited to innovations in ultrasound, computed tomography, and magnetic resonance imaging, making it essential for professionals looking to stay at the forefront of imaging science. While it operates under a subscription model, its extensive archive of influential articles ensures ongoing access to critical knowledge and developments in the field. With a commitment to quality and relevance, SEMINARS IN ULTRASOUND CT AND MRI continues to contribute significantly to the evolving landscape of medical imaging.

Hamostaseologie

Innovative Discoveries in Hematology: Shaping the Future of Coagulation
Publisher: GEORG THIEME VERLAG KGISSN: 0720-9355Frequency: 4 issues/year

Hamostaseologie is a prominent academic journal dedicated to the field of hematology, published by GEORG THIEME VERLAG KG. With an ISSN of 0720-9355 and an E-ISSN of 2567-5761, this journal has been at the forefront of critical research and advancements since its inception in 1981, and it continues to maintain its relevance in the scientific community with a converged publication until 2024. Ranked in the Q3 quartile in Hematology for 2023, and positioned at #44 out of 137 in the Scopus Medicine Hematology category, it represents a substantial contribution to scholarly discourse. Researchers and professionals alike will find valuable insights within its pages, as it disseminates rigorous studies and reviews that address pertinent issues related to hemostasis and coagulation. While the journal does not currently offer Open Access, readers can access its valuable content through institutional subscriptions, making it an essential resource for students, clinicians, and researchers aiming to deepen their understanding of hematological science.

Blood Research

Advancing Hematological Science for a Healthier Tomorrow
Publisher: SPRINGERISSN: 2287-979XFrequency: 4 issues/year

Blood Research, published by SPRINGER, is a premier journal dedicated to the multifaceted realm of hematology, serving as a crucial platform for disseminating innovative research findings and advancements in the diagnosis and treatment of blood-related disorders. With an ISSN of 2287-979X and an E-ISSN of 2288-0011, this journal is recognized for its commitment to scholarly excellence and impact in the field, currently holding a reputable Q2 ranking in the Hematology category as per the 2023 metrics. The journal spans from 2013 to 2024, providing a broad archive of quality research that is vital for researchers, healthcare professionals, and students alike. Although it is not an Open Access journal, it offers insightful contributions that enhance the understanding of hematological science, fostering the exchange of knowledge crucial for advancing patient care and clinical practices globally. The journal’s performance is underscored by its Scopus ranking in the 46th percentile, reflecting its significant role in the ongoing discourse in hematology.

RHEUMATOLOGY INTERNATIONAL

Empowering researchers and clinicians with vital insights.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

INTERNATIONAL JOURNAL OF HEMATOLOGY

Navigating the Future of Blood Health Research
Publisher: SPRINGER JAPAN KKISSN: 0925-5710Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.

CURRENT OPINION IN HEMATOLOGY

Connecting groundbreaking research to clinical practice.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1065-6251Frequency: 6 issues/year

CURRENT OPINION IN HEMATOLOGY is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and insights in the field of hematology. With an impressive impact factor and ranked in the first quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and students seeking to stay informed on contemporary issues and emerging trends in hematological research and treatment. Established in 1994, it showcases critical reviews, expert commentary, and systematic analyses across a broad spectrum of hematology topics, contributing significantly to clinical and experimental knowledge through its robust editorial standards. While offering traditional subscription access, CURRENT OPINION IN HEMATOLOGY remains committed to providing a platform that bridges the gap between fundamental research and clinical application, making it indispensable for professionals dedicated to advancing patient care and scientific understanding in hematology.

Hematology-American Society of Hematology Education Program

Transforming Hematology through Comprehensive Learning
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

Thrombosis Journal

Advancing knowledge in thrombotic diseases.
Publisher: BMCISSN: 1477-9560Frequency: 1 issue/year

Thrombosis Journal is a pioneering open-access publication offering critical insights into the field of hematology, contributing significantly to the understanding of thrombotic diseases. Published by BMC since its inception in 2003, this journal stands out with its commitment to accessibility and dissemination of research, ensuring that valuable findings are readily available to the global scientific community. With an impressive Q2 ranking in the Hematology category as of 2023, the journal boasts a notable presence in the Scopus rankings, positioned at Rank #73/137 in its field. Researchers, healthcare professionals, and students can benefit from a rich array of articles that encompass clinical studies, reviews, and innovative methodologies, all aimed at advancing knowledge and fostering collaboration in the field. The journal is headquartered in the United Kingdom, and its open-access model has enabled a diversity of perspectives and research innovations to flourish, solidifying Thrombosis Journal as an essential resource for those dedicated to combating thrombotic disorders.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Leading the Way in Hematology Innovation
Publisher: ELSEVIER SCIENCE INCISSN: 1538-7933Frequency: 12 issues/year

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, published by Elsevier Science Inc, stands at the forefront of research in the fields of hematology and medicine, boasting an impressive ranking of #5 out of 137 in Scopus's Medicine - Hematology category, with a remarkable 96th percentile. As an essential resource for researchers, clinicians, and students, this journal, identifiable through its ISSN 1538-7933 and E-ISSN 1538-7836, encompasses pioneering studies and reviews that focus on the mechanisms of thrombosis and hemostasis, contributing significantly to advancements in patient care and therapeutic strategies. With an established presence from 2003 through 2024, it has consistently achieved a prestigious Q1 category ranking, reflecting its impactful contributions to the scientific community. Although it operates under a subscription-based model, the journal remains committed to disseminating significant findings that inform best practices in clinical settings and shape future research trajectories.

Molecular Genetics & Genomic Medicine

Advancing the frontiers of genomic medicine.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.